FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067212901> ?p ?o ?g. }

• W2067212901 endingPage "2563" @default.
• W2067212901 startingPage "2554" @default.
• W2067212901 abstract "ABSTRACT Plazomicin is a next-generation aminoglycoside that is not affected by most clinically relevant aminoglycoside-modifying enzymes. The in vitro activities of plazomicin and comparator antimicrobials were evaluated against a collection of 5,015 bacterial isolates obtained from patients in Canadian hospitals between January 2011 and October 2012. Susceptibility testing was performed using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method, with MICs interpreted according to CLSI breakpoints, when available. Plazomicin demonstrated potent in vitro activity against members of the family Enterobacteriaceae , with all species except Proteus mirabilis having an MIC 90 of ≤1 μg/ml. Plazomicin was active against aminoglycoside-nonsusceptible Escherichia coli , with MIC 50 and MIC 90 values identical to those for aminoglycoside-susceptible isolates. Furthermore, plazomicin demonstrated equivalent activities versus extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing E. coli and Klebsiella pneumoniae , with 90% of the isolates inhibited by an MIC of ≤1 μg/ml. The MIC 50 and MIC 90 values for plazomicin against Pseudomonas aeruginosa were 4 μg/ml and 16 μg/ml, respectively, compared with 4 μg/ml and 8 μg/ml, respectively, for amikacin. Plazomicin had an MIC 50 of 8 μg/ml and an MIC 90 of 32 μg/ml versus 64 multidrug-resistant P. aeruginosa isolates. Plazomicin was active against methicillin-susceptible and methicillin-resistant Staphylococcus aureus , with both having MIC 50 and MIC 90 values of 0.5 μg/ml and 1 μg/ml, respectively. In summary, plazomicin demonstrated potent in vitro activity against a diverse collection of Gram-negative bacilli and Gram-positive cocci obtained over a large geographic area. These data support further evaluation of plazomicin in the clinical setting." @default.
• W2067212901 created "2016-06-24" @default.
• W2067212901 creator A5033454548 @default.
• W2067212901 creator A5034066865 @default.
• W2067212901 creator A5040054328 @default.
• W2067212901 creator A5048766617 @default.
• W2067212901 creator A5051398176 @default.
• W2067212901 creator A5061522332 @default.
• W2067212901 creator A5071438112 @default.
• W2067212901 creator A5090227234 @default.
• W2067212901 date "2014-05-01" @default.
• W2067212901 modified "2023-09-26" @default.
• W2067212901 title "<i>In Vitro</i> Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012" @default.
• W2067212901 cites W1918435573 @default.
• W2067212901 cites W2024578173 @default.
• W2067212901 cites W2036244463 @default.
• W2067212901 cites W2048550794 @default.
• W2067212901 cites W2049888829 @default.
• W2067212901 cites W2065791238 @default.
• W2067212901 cites W2090369174 @default.
• W2067212901 cites W2095675572 @default.
• W2067212901 cites W2100869224 @default.
• W2067212901 cites W2102467528 @default.
• W2067212901 cites W2103121782 @default.
• W2067212901 cites W2110803731 @default.
• W2067212901 cites W2117532887 @default.
• W2067212901 cites W2125893214 @default.
• W2067212901 cites W2127653962 @default.
• W2067212901 cites W2129842338 @default.
• W2067212901 cites W2133611232 @default.
• W2067212901 cites W2142205576 @default.
• W2067212901 cites W2145111808 @default.
• W2067212901 cites W2146531212 @default.
• W2067212901 cites W2154007902 @default.
• W2067212901 cites W2157925105 @default.
• W2067212901 cites W2169744731 @default.
• W2067212901 doi "https://doi.org/10.1128/aac.02744-13" @default.
• W2067212901 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3993217" @default.
• W2067212901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24550325" @default.
• W2067212901 hasPublicationYear "2014" @default.
• W2067212901 type Work @default.
• W2067212901 sameAs 2067212901 @default.
• W2067212901 citedByCount "102" @default.
• W2067212901 countsByYear W20672129012014 @default.
• W2067212901 countsByYear W20672129012015 @default.
• W2067212901 countsByYear W20672129012016 @default.
• W2067212901 countsByYear W20672129012017 @default.
• W2067212901 countsByYear W20672129012018 @default.
• W2067212901 countsByYear W20672129012019 @default.
• W2067212901 countsByYear W20672129012020 @default.
• W2067212901 countsByYear W20672129012021 @default.
• W2067212901 countsByYear W20672129012022 @default.
• W2067212901 countsByYear W20672129012023 @default.
• W2067212901 crossrefType "journal-article" @default.
• W2067212901 hasAuthorship W2067212901A5033454548 @default.
• W2067212901 hasAuthorship W2067212901A5034066865 @default.
• W2067212901 hasAuthorship W2067212901A5040054328 @default.
• W2067212901 hasAuthorship W2067212901A5048766617 @default.
• W2067212901 hasAuthorship W2067212901A5051398176 @default.
• W2067212901 hasAuthorship W2067212901A5061522332 @default.
• W2067212901 hasAuthorship W2067212901A5071438112 @default.
• W2067212901 hasAuthorship W2067212901A5090227234 @default.
• W2067212901 hasBestOaLocation W20672129011 @default.
• W2067212901 hasConcept C104317684 @default.
• W2067212901 hasConcept C176947019 @default.
• W2067212901 hasConcept C2777058267 @default.
• W2067212901 hasConcept C2777427914 @default.
• W2067212901 hasConcept C2777637488 @default.
• W2067212901 hasConcept C2777787772 @default.
• W2067212901 hasConcept C2778039505 @default.
• W2067212901 hasConcept C2780950330 @default.
• W2067212901 hasConcept C4937899 @default.
• W2067212901 hasConcept C501593827 @default.
• W2067212901 hasConcept C523546767 @default.
• W2067212901 hasConcept C54355233 @default.
• W2067212901 hasConcept C547475151 @default.
• W2067212901 hasConcept C55493867 @default.
• W2067212901 hasConcept C71924100 @default.
• W2067212901 hasConcept C86803240 @default.
• W2067212901 hasConcept C89423630 @default.
• W2067212901 hasConceptScore W2067212901C104317684 @default.
• W2067212901 hasConceptScore W2067212901C176947019 @default.
• W2067212901 hasConceptScore W2067212901C2777058267 @default.
• W2067212901 hasConceptScore W2067212901C2777427914 @default.
• W2067212901 hasConceptScore W2067212901C2777637488 @default.
• W2067212901 hasConceptScore W2067212901C2777787772 @default.
• W2067212901 hasConceptScore W2067212901C2778039505 @default.
• W2067212901 hasConceptScore W2067212901C2780950330 @default.
• W2067212901 hasConceptScore W2067212901C4937899 @default.
• W2067212901 hasConceptScore W2067212901C501593827 @default.
• W2067212901 hasConceptScore W2067212901C523546767 @default.
• W2067212901 hasConceptScore W2067212901C54355233 @default.
• W2067212901 hasConceptScore W2067212901C547475151 @default.
• W2067212901 hasConceptScore W2067212901C55493867 @default.
• W2067212901 hasConceptScore W2067212901C71924100 @default.
• W2067212901 hasConceptScore W2067212901C86803240 @default.
• W2067212901 hasConceptScore W2067212901C89423630 @default.
• W2067212901 hasIssue "5" @default.

• next